Cargando…

Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study

PURPOSE: To evaluate the appropriateness of laboratory-test monitoring recommended for patients on chronic medication therapies in the Lebanese community setting. PATIENTS AND METHODS: In October 2011, all outpatients visiting selected community pharmacies in Lebanon were screened by pharmacists to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramia, Elsy, Zeenny, Rony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162632/
https://www.ncbi.nlm.nih.gov/pubmed/25228798
http://dx.doi.org/10.2147/PPA.S69250
_version_ 1782334699795906560
author Ramia, Elsy
Zeenny, Rony
author_facet Ramia, Elsy
Zeenny, Rony
author_sort Ramia, Elsy
collection PubMed
description PURPOSE: To evaluate the appropriateness of laboratory-test monitoring recommended for patients on chronic medication therapies in the Lebanese community setting. PATIENTS AND METHODS: In October 2011, all outpatients visiting selected community pharmacies in Lebanon were screened by pharmacists to evaluate their use of one or more chronic medications requiring safety and/or therapeutic laboratory tests. The list of medications was elaborated after an extensive review of laboratory-test monitoring recommendations from pertinent up-to-date clinical guidelines, medications that have been issued black box warnings for monitoring, and the most current information from the US Food and Drug Administration website. Patients receiving these medications were subjected to a questionnaire assessing the appropriateness of their laboratory-test monitoring. The study was approved by the Lebanese American University’s Institutional Review Board. RESULTS: A total of 284 outpatients, with almost equal distribution by sex, were identified during the aforementioned period to be on one or more of the specified medications. The majority of the sample (68%) was younger than 65 years of age. Overall, most of the study group (65%) were found to be partially monitored with laboratory tests, while only 27% were fully monitored and 8% were not monitored at all. The study group reported clinic-visit intervals as follows: more than a year (35%), on yearly basis (18%), every 6 months (25%), every 3 months (16%), less than 3 months (6%). CONCLUSION: Seventy-three percent (73%) of the study group were receiving incomplete therapeutic/safety laboratory-test monitoring recommended for patients on chronic medication in the Lebanese community. It is concluded from the results that patients need to better understand the importance of recommended test monitoring for the safe and effective use of their medications. Education by physicians may be required to achieve better understanding.
format Online
Article
Text
id pubmed-4162632
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-41626322014-09-16 Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study Ramia, Elsy Zeenny, Rony Patient Prefer Adherence Original Research PURPOSE: To evaluate the appropriateness of laboratory-test monitoring recommended for patients on chronic medication therapies in the Lebanese community setting. PATIENTS AND METHODS: In October 2011, all outpatients visiting selected community pharmacies in Lebanon were screened by pharmacists to evaluate their use of one or more chronic medications requiring safety and/or therapeutic laboratory tests. The list of medications was elaborated after an extensive review of laboratory-test monitoring recommendations from pertinent up-to-date clinical guidelines, medications that have been issued black box warnings for monitoring, and the most current information from the US Food and Drug Administration website. Patients receiving these medications were subjected to a questionnaire assessing the appropriateness of their laboratory-test monitoring. The study was approved by the Lebanese American University’s Institutional Review Board. RESULTS: A total of 284 outpatients, with almost equal distribution by sex, were identified during the aforementioned period to be on one or more of the specified medications. The majority of the sample (68%) was younger than 65 years of age. Overall, most of the study group (65%) were found to be partially monitored with laboratory tests, while only 27% were fully monitored and 8% were not monitored at all. The study group reported clinic-visit intervals as follows: more than a year (35%), on yearly basis (18%), every 6 months (25%), every 3 months (16%), less than 3 months (6%). CONCLUSION: Seventy-three percent (73%) of the study group were receiving incomplete therapeutic/safety laboratory-test monitoring recommended for patients on chronic medication in the Lebanese community. It is concluded from the results that patients need to better understand the importance of recommended test monitoring for the safe and effective use of their medications. Education by physicians may be required to achieve better understanding. Dove Medical Press 2014-09-08 /pmc/articles/PMC4162632/ /pubmed/25228798 http://dx.doi.org/10.2147/PPA.S69250 Text en © 2014 Ramia and Zeenny. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Ramia, Elsy
Zeenny, Rony
Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study
title Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study
title_full Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study
title_fullStr Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study
title_full_unstemmed Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study
title_short Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study
title_sort completion of therapeutic and safety monitoring tests in lebanese outpatients on chronic medications: a cross-sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162632/
https://www.ncbi.nlm.nih.gov/pubmed/25228798
http://dx.doi.org/10.2147/PPA.S69250
work_keys_str_mv AT ramiaelsy completionoftherapeuticandsafetymonitoringtestsinlebaneseoutpatientsonchronicmedicationsacrosssectionalstudy
AT zeennyrony completionoftherapeuticandsafetymonitoringtestsinlebaneseoutpatientsonchronicmedicationsacrosssectionalstudy